| Description | Date | Event Coding |
|---|
| NEW APPLICATION ENTERED | 2021-11-27 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2021-11-30 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2022-09-06 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-09-06 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-09-21 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-10-11 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-10-11 | 7 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-12-06 | 8 NOAM E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2023-05-24 | 9 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2023-05-24 | 10 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2023-05-24 | 11 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-05-26 | 12 EXRA E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-09-27 | 13 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-09-27 | 14 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-09-27 | 15 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-09-27 | 16 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-09-27 | 17 TCCA I:Incoming Correspondence |
| SOU TEAS EXTENSION RECEIVED | 2023-11-17 | 18 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2023-11-17 | 19 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2023-11-17 | 20 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-11-21 | 21 EXRA E:E-Mail |
| SOU TEAS EXTENSION RECEIVED | 2024-03-01 | 22 EEXT I:Incoming Correspondence |
| TEAS STATEMENT OF USE RECEIVED | 2024-03-01 | 23 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2024-03-21 | 24 AITU A:Allowance for Publication |
| TEAS REQUEST TO DIVIDE RECEIVED | 2024-03-01 | 25 ERTD I:Incoming Correspondence |
| DIVISIONAL REQUEST RECEIVED | 2024-03-01 | 26 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2024-04-18 | 27 DPCC D:Assigned to Examiner |
| SOU EXTENSION 3 FILED | 2024-03-01 | 28 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2024-03-01 | 29 EX3G S: |
| USE AMENDMENT FILED | 2024-03-01 | 30 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2024-04-18 | 31 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-04-18 | 32 EXRA E:E-Mail |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2024-05-09 | 33 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2024-05-09 | 34 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2024-06-11 | 35 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-06-11 | 36 NRCC E:E-Mail |
Arsenal Biosciences, Inc.
| 